Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0200
-0.0010 (-5.00%)
Aug 13, 2025, 3:56 PM HKT

Aceso Life Science Group Ratios and Metrics

Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
1483691,1741,3144721,574
Upgrade
Market Cap Growth
-68.55%-68.55%-10.67%178.13%-69.98%28.51%
Upgrade
PS Ratio
-2.08-5.20106.706.352.78-12.20
Upgrade
PB Ratio
0.200.500.650.510.170.52
Upgrade
P/FCF Ratio
9.8424.61-6.921.829.60
Upgrade
P/OCF Ratio
8.6821.71-6.141.508.79
Upgrade
Debt / Equity Ratio
3.093.091.511.141.070.95
Upgrade
Debt / FCF Ratio
153.40153.40-15.3811.6217.51
Upgrade
Quick Ratio
0.260.260.560.490.731.49
Upgrade
Current Ratio
0.280.280.570.700.931.93
Upgrade
Asset Turnover
--0.000.030.03-
Upgrade
Return on Equity (ROE)
-79.55%-79.55%-36.87%-7.70%-20.41%-12.63%
Upgrade
Return on Assets (ROA)
-25.33%-25.33%-14.59%-3.31%-9.59%-6.21%
Upgrade
Earnings Yield
-606.22%-242.49%-39.36%-20.09%-78.32%-23.89%
Upgrade
Earnings Yield
-606.22%-242.49%-39.36%-20.09%-78.32%-23.89%
Upgrade
FCF Yield
10.16%4.06%-4.09%14.46%54.82%10.42%
Upgrade
Buyback Yield / Dilution
1.06%1.06%0.60%1.63%-6.06%-21.39%
Upgrade
Updated Dec 20, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.